## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, doubleβblind, placeboβcontrolled trial co
β¦ LIBER β¦
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
β Scribed by Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Goldstein; Smriti Iyengar; Joachim F. Wernicke
- Book ID
- 116817689
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 265 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0304-3959
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A double-blind, multicenter trial compar
β
Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D
π
Article
π
2004
π
John Wiley and Sons
π
English
β 115 KB
π 2 views
Efficacy and safety of duloxetine for tr
β
I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine
π
Article
π
2008
π
Elsevier Science
π
English
β 608 KB
Duloxetine in the treatment of major dep
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
β
D.G.S. Perahia; F. Wang; C.H. Mallinckrodt; D.J. Walker; M.J. Detke
π
Article
π
2006
π
Elsevier Science
π
French
β 568 KB
Flexible dosed duloxetine versus placebo
β
D. Clauw; L. Arnold; F. Wang; J. Ahl; P. Gaynor; M. Wohlreich
π
Article
π
2010
π
Elsevier Science
π
English
β 37 KB
A randomized, double-blind comparison of
β
David G.S. Perahia; Yili Lu Pritchett; Daniel K. Kajdasz; Michael Bauer; Rakesh
π
Article
π
2008
π
Elsevier Science
π
English
β 429 KB
Gabapentin in the treatment of fibromyal
β
Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H.
π
Article
π
2007
π
John Wiley and Sons
π
English
β 168 KB
π 3 views
## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12βweek, randomized, doubleβblind study was designed to compare gabapentin (1,200β2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin